-
The Route Not Taken. EP9
Leveraging ChemAIRS to Investigate Synthetic Strategies for SGR-1505, a MALT1 inhibitor from Schrodinger
넶0 2024-09-25 -
The Route Not Taken. EP8
Leveraging ChemAIRS to Investigate Synthetic Strategies for Chiral Spirocyclic Isoxazolone, a Vital Building Block in a Boehringer Ingelheim Drug Development Program.
넶0 2024-09-25 -
The Route Not Taken. EP7
Utilizing ChemAIRS to Explore Synthetic Strategies of Azabenzimidazolone: A Potent αvβ1 Integrin Antifibrotic by Takeda
넶0 2024-09-24 -
The Route Not Taken. EP6
Use ChemAIRS to Investigate Synthesis Strategies of OX2R Modulator, a Vertex Pharmaceuticals' Approach to Narcolepsy Treatment
넶5 2024-08-08 -
The Route Not Taken. EP5
Utilizing ChemAIRS to Investigate Synthetic Strategies of WRN Inhibitor HRO761: A Potential Therapeutic from Novartis for MSI Cancers
넶4 2024-08-01 -
The Route Not Taken. EP4
Rapidly Identifying Alternative Synthetic Routes for Merck & Co.’s KRAS G12C Inhibitor
넶3 2024-07-25
ꁲ
ꁲ
